Handbook of HER2-targeted agents in breast cancer

• Κύριοι συγγραφείς: Alvarez, Ricardo H. (Συγγραφέας), Cortés, Javier (Συγγραφέας), Mattos-Arruda, Leticia De (Συγγραφέας), Falzon, Mary (Συγγραφέας), Fasolo, Angelica (Συγγραφέας), Gandy, Michael (Συγγραφέας), Gianni, Luca (Συγγραφέας), Harbeck, Nadia (Συγγραφέας), Piccart, Martine (Συγγραφέας), Zambelli, Stefania (Συγγραφέας), Zardavas, Dimitrios (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Tarporley : Springer Healthcare Ltd. : Imprint: Springer Healthcare, 2013.
• Θέματα: Medicine.; General practice (Medicine).; Internal medicine.; Oncology.; Primary care (Medicine).; Pharmacotherapy.; Medicine & Public Health.; Primary Care Medicine.; General Practice / Family Medicine.; Internal Medicine.

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year.  Of these cases, approximately  15–25% overexpress HER2, a transmembrane RTK kinase that is associated with aggress...

Πίνακας περιεχομένων:

• Introduction and background biology
• HER2 testing
• HER2-positive breast cancer: adjuvant and neoadjuvant therapy
• HER2-positive metastatic breast cancer: first-line treatment
• HER2-positive metastatic breast cancer: second-line treatment
• Emerging targeted agents for HER2-positive breast cancer.